N#CC(/C(CCCC(=O)Nc1cccc([N+](=O)[O-])c1)=N\NC(=O)c1c(O)ccc2ccccc12)c1nc2ccccc2s1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?